Bay Street News, March, 2024

Fourth Quarter 2023 Total Revenues of $277 million, which aligned our Full Year to the mid-point of guidance Full Year […]

ROCKVILLE, Md., March 06, 2024 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and […]

BETHESDA, Md., March 06, 2024 (GLOBE NEWSWIRE) — Liquidity Services (NASDAQ: LQDT), a leading global commerce company powering the circular […]

ATLANTA, March 06, 2024 (GLOBE NEWSWIRE) — Acuity Brands, Inc. (NYSE: AYI) (the “Company”) today announced that it is planning […]

GAAP EPS of $0.57 – unchanged YoY; Non-GAAP EPS*increased to $0.67 from $0.62 Cash, cash equivalents, debt securities, and current […]

WATERTOWN, Mass., March 06, 2024 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, […]

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical […]

BOSTON, March 06, 2024 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (“DraftKings” or the “Company”) today announced that Jason Robins, […]

MISSISSAUGA, Ontario, March 06, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its […]

Denver, CO, March 06, 2024 (GLOBE NEWSWIRE) — Intrepid Potash, Inc. (NYSE:IPI) (“Intrepid”, the “Company”, “we”, “us” and “our”) [...]